Unichem Laboratories Ltd receives ANDA approval for Prasugrel Tablets

Unichem Laboratories Limited has received ANDA approval for its Prasugrel Tablets USP, 5 mg and 10 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Effient® (Prasugrel) Tablets, 5 mg and 10 mg, of Cosette Pharmaceuticals, Inc.

Prasugrel tablets are indicated to reduce the rate of thrombotic CV events (including stent thrombosis) in patients with acute coronary syndrome. The product will be commercialized from Unichem's Goa Plant.

Shares of Unichem Laboratories Limited was last trading in BSE at Rs. 417.10 as compared to the previous close of Rs. 414.90. The total number of shares traded during the day was 1720 in over 106 trades.

The stock hit an intraday high of Rs. 417.85 and intraday low of 413.30. The net turnover during the day was Rs. 716681.00.

Source : Equity Bulls

Keywords

UnichemLaboratories INE351A01035 USFDA ANDA Approval PrasugrelTablets